Get started
Gimv - long Gimv is a European investment company, listed on Euronext Brussels. Price recently had a big push from around 48.5 to 52.6, all in a single week. Price has come down from those levels, and is ranging sideways in a tight range. Tight sideways price range after a breakout is a strong signal for trend continuation. Trend is bullish because MA 50 is above MA 200, with recent cross over on Jan 6, and seems to continue widening. RSI is > 50. Next resistance is last recent high of around 52.6, then the zone of 54.3 and 54.9. Should these levels break, the way is clear towards 56.4 - 56.9. All time high is at 59.6. Price levels below around 48.4 would invalidate the bullish scenario. Keen to know what others think. Please follow BradtNom, leave a comment or link to your own ideas! Charts are for information purposes only. Not trade suggestions. DYOR (Do your own research) - act responsibly with your money.
EURONEXT:GIMBLong
by BradtNom
Sanofi - bullish continuation confirmed on 4HSanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, as of 2013 the world's fifth-largest by prescription sales. Shown here is the daily chart, with monthly zones/lines of support (green dashed lines) and resistance (red dashed lines). Also shown is a Fibonacci drawn on the monthly chart. In the 4H, Sanofi is clearly bullish ( recent breakout of green Heikin Ashi candles, price above the 50 and 200 MA, recent cross over of 50/200 MA on 4H, and an RSI > 50. Price recently dipped a bit to the downside, but recovered, and is in the 23.8% Fibonacci zone, to which it has returned. On the daily chart, price is between the 50-day MA and 200-day MA, which appears to be crossing over soon. This would be a bullish signal on Daily chart if it happens. If price does move upward, the there are several levels of resistance (monthly), namely at around 83.57, 86.33, 92.94. 95.86 and the all time high of 101.06. A price drop down to 79.00/80.00 would invalidate the bullish signal. Keen to know what others think. Please leave a comment or link to your own ideas! Charts are for information purposes only. Not trade suggestions. DYOR (Do your own research) - act responsibly with your money.
EURONEXT:SANLong
by BradtNom
Sanofi consolidates, new bullish trend in 2022I expect the price of Sanofi to carry on falling inside the descending channel, especially if global market consolidates due to rising inflation fears. Sanofi has not been able to produce a covid vaccine and is just starting phase I/II trials for a second vaccine candidate which leaves the near future a bit blurry and may keep investors away. Once the price has reached the bottom of the horizontal range (64 EUR) I expect a reversal for a new bullish trend towards 95EUR by end of 2022.
EURONEXT:SAN
by Jeff_Trad